Carregant...
A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics
Rexinoids are powerful ligands that bind to retinoid-X-receptors (RXRs) and show great promise as therapeutics for a wide range of diseases, including cancer. However, only one rexinoid, bexarotene (Targretin TM) has been successfully transitioned from the bench to the clinic and used to treat cutan...
Guardat en:
| Publicat a: | Steroids |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5977990/ https://ncbi.nlm.nih.gov/pubmed/29704526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.steroids.2018.04.009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|